BHARATRAS1,178.00

Bharat Rasayan Limited

· Chemicals
AnnualQuarterly₹ CrorePeersINSECTICIDIPLMOLGSPCROPPUNJABCHEMASTECBHAGCHEMNACLINDMcap ₹1,958 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations1,044.61,173.01,241.81,202.6
Other Income20.926.041.239.7
Total Income1,065.51,199.01,283.11,242.3
Expenses
+ Cost of Materials Consumed678.1824.5799.2819.4
+ Changes in Inventories43.0-47.66.6-37.7
+ Employee Benefit Expense84.585.490.593.2
+ Finance Costs3.04.74.64.4
+ Depreciation & Amortisation25.827.026.427.0
+ Other Expenses121.8135.8146.4151.0
Total Expenses956.11,029.81,073.71,057.3
EBITDA117.3174.9199.1176.7
EBIT91.5147.9172.8149.7
Profit
PBT before Exceptional Items109.4169.2209.4185.0
+ Exceptional Items0.00.0-18.8-4.0
Pretax Income109.4169.2190.6181.0
+ Current Tax25.339.743.544.8
+ Deferred Tax2.54.44.20.3
Tax Expense27.844.147.745.1
+ Share of Associates & JVs13.915.82.84.0
Net Income95.5140.9145.7139.9
+ Net Income — Continuing Ops81.6125.1142.9135.9
+ Other Comprehensive Income-0.20.1-0.4-0.5
Total Comprehensive Income95.3141.0145.3139.3
Per Share
Basic EPS229.86339.1487.67136.53
Diluted EPS229.86339.1487.67136.53
Other Comprehensive Income — detail
+ Other Comprehensive Income0.1-0.4-0.5
+ Tax on Items NOT to be Reclassified-0.10.40.5
+ Tax on Items NOT to be Reclassified — alt tag0.2
Per Share — as-filed variants
Basic EPS — Continuing Operations229.86339.1487.67136.53
Diluted EPS — Continuing Operations229.86339.1487.67136.53
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit323.6396.0436.1420.9
Gross Margin %30.9833.7635.1135.00
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)109.4169.2209.4185.0
− Exceptional Items (reconciliation)0.00.0-18.8-4.0
Net Income Adj (tax-effected)95.5140.9159.8142.9
EPS Adj229.86339.1496.16139.49
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.005.005.00
Paid Up Equity Capital4.24.28.38.3
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.